1![Sepsis First Dose Empirical Intravenous Antibiotic Guideline Adult - Emergency Department The Clinical Excellence Commission adult Sepsis first dose Empirical Intravenous Antibiotic Guideline for emergency departments ai Sepsis First Dose Empirical Intravenous Antibiotic Guideline Adult - Emergency Department The Clinical Excellence Commission adult Sepsis first dose Empirical Intravenous Antibiotic Guideline for emergency departments ai](https://www.pdfsearch.io/img/c695c4597512ac500d006a488390b746.jpg) | Add to Reading ListSource URL: www.cec.health.nsw.gov.auLanguage: English |
---|
2![Absorption of lincomycin through the respiratory pathways and its influence on alveolar macrophages after aerosol administration to chickens Absorption of lincomycin through the respiratory pathways and its influence on alveolar macrophages after aerosol administration to chickens](https://www.pdfsearch.io/img/93a515edd34bc5cc422b10107c35ebb1.jpg) | Add to Reading ListSource URL: eurekamag.comLanguage: English - Date: 2014-09-26 05:50:08
|
---|
3![Lincocin® lincomycin injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of Lincocin® lincomycin injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of](https://www.pdfsearch.io/img/96fc9b9589fc8e331fd98aa1d2caff7e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-10-16 11:32:59
|
---|
4![BenzaClin® Topical Gel (clindamycin - benzoyl peroxide gel) Topical Gel: clindamycin (1%) as clindamycin phosphate, benzoyl peroxide (5%) For Dermatological Use Only - Not for Ophthalmic Use BenzaClin® Topical Gel (clindamycin - benzoyl peroxide gel) Topical Gel: clindamycin (1%) as clindamycin phosphate, benzoyl peroxide (5%) For Dermatological Use Only - Not for Ophthalmic Use](https://www.pdfsearch.io/img/c3cd786193da6963bc449616b7846d09.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-06-22 00:26:42
|
---|
5![DATE OF APPROVAL LETTER: FEB 28, 2002 FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA[removed] DATE OF APPROVAL LETTER: FEB 28, 2002 FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA[removed]](https://www.pdfsearch.io/img/7d8a874c31e8761ec8967871e1e79cd3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![Lincomycin Hydrochloride Blue Bird Label Lincomycin Hydrochloride Blue Bird Label](https://www.pdfsearch.io/img/eb69e80173a1ed25d8c4d395a53b95f5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![Date of Approval:_February 1, 2002 FREEDOM OF INFORMATION SUMMARY ANADA[removed]Indication for use: For treatment of infectious arthritis and mycoplasma pneumonia in swine Date of Approval:_February 1, 2002 FREEDOM OF INFORMATION SUMMARY ANADA[removed]Indication for use: For treatment of infectious arthritis and mycoplasma pneumonia in swine](https://www.pdfsearch.io/img/6ffdbc3cf2cfdb837fa77b2de3fd6de4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
8![Minimum Inhibitory Concentration and Minimum Bactericidal Concentration Results for Brachyspira species - What is the Difference? Minimum Inhibitory Concentration and Minimum Bactericidal Concentration Results for Brachyspira species - What is the Difference?](https://www.pdfsearch.io/img/5c7bc724c606e29bfa5a4e4934fe2560.jpg) | Add to Reading ListSource URL: www.octagon-services.co.ukLanguage: English - Date: 2014-05-29 10:22:41
|
---|
9![Ivermectin/Lincomycin - Type B- Swine Ivermectin/Lincomycin - Type B- Swine](https://www.pdfsearch.io/img/61e4a7b2d56a13521fef3d42891ef191.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![Lincomycin Hydrochloride Blue Bird Label Lincomycin Hydrochloride Blue Bird Label](https://www.pdfsearch.io/img/7835f9a8d253aa626ba5b4c8b4269433.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|